Additionally, the YAP-specific inhibitor VP can alleviate the severity of symptoms in AD mouse models by blocking inflammatory factors and the JAK-STAT pathway, indicating that YAP contributes to the inflammatory characteristics of the disease (98, 99). Here, YAP1 is linked to Alzheimer disease.